Back to Search Start Over

Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside

Authors :
Aron, Emmi
Iro, Boura
Vanessa, Raeder
Donna, Mathew
David, Sulzer
James E, Goldman
Valentina, Leta
Source :
International review of neurobiology. 165
Publication Year :
2022

Abstract

Coronavirus disease 2019 (Covid-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is primarily regarded as a respiratory disease; however, multisystemic involvement accompanied by a variety of clinical manifestations, including neurological symptoms, are commonly observed. There is, however, little evidence supporting SARS-CoV-2 infection of central nervous system cells, and neurological symptoms for the most part appear to be due to damage mediated by hypoxic/ischemic and/or inflammatory insults. In this chapter, we report evidence on candidate neuropathological mechanisms underlying neurological manifestations in Covid-19, suggesting that while there is mostly evidence against SARS-CoV-2 entry into brain parenchymal cells as a mechanism that may trigger Parkinson's disease and parkinsonism, that there are multiple means by which the virus may cause neurological symptoms.

Details

ISSN :
21625514
Volume :
165
Database :
OpenAIRE
Journal :
International review of neurobiology
Accession number :
edsair.pmid..........1e74526d4781d5727234f3bd62a41670